Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336

Peringkat dalam Saham #3772
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Harga Saham
$4.87
Kapitalisasi Pasar
$4.36B
Perubahan (1 hari)
-5.47%
Perubahan (1 tahun)
-15.62%
Negara
CN
Perdagangan Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

Kategori

Healthcare
Riwayat dividen untuk Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Saham Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (simbol: 688336) telah membayar total 5 dividen.
Total semua dividen (disesuaikan dengan stock split): $0.63
Imbal hasil dividen (TTM): 0.0149
Pembayaran dividen untuk Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336) dari 2024 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
2026 (TTM) $0.45 265.85%
2025 $0.123 114.66%
2024 $0.0573 0.00%
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
2026 (TTM) $0.6525 265.75%
2025 $0.1784 114.94%
2024 $0.083 0.00%
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
0.00%
US
0.00%
US
67.00%
AU
30.00%
BE
0.00%
NL